Form D — SAB Biotherapeutics, Inc.
0000950123-25-007031 · filed 2025-08-05
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $175,000,000
- Total sold
- $175,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SAB Biotherapeutics, Inc.
- CIK
- 1833214
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 777 W 41st St
Miami Beach, FL 33140 - Phone
- 305 845-2813
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Samuel Reich · Executive OfficerMiami Beach, FL Find on LinkedIn ↗
-
Eddie Sullivan · Executive OfficerMiami Beach, FL Find on LinkedIn ↗
-
Katie Ellias · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Scott Giberson · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Christine Hamilton · DirectorMiami Beach, FL Find on LinkedIn ↗
-
David Link · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Erick Lucera · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Andrew Moin · DirectorMiami Beach, FL Find on LinkedIn ↗
-
William Polvino · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Jay Skyler · DirectorMiami Beach, FL Find on LinkedIn ↗
-
Jeffrey Spragens · DirectorMiami Beach, FL Find on LinkedIn ↗
View original on SEC EDGAR.